Ventyx biosciences to participate in the jefferies global healthcare conference

San diego, may 28, 2025 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”, “company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today announced that company executives will participate in a fireside chat at the upcoming jefferies global healthcare conference. event: jefferies global healthcare conference, new york fireside chatdate: thursday, june 5, 2025 time: 12:50-1:20 pm et a webcast of the event will be available in the investors and news section of the ventyx website at  www.ventyxbio.com.
VTYX Ratings Summary
VTYX Quant Ranking